Janssen Emergency Use Authorization
An Emergency Use Authorization (EUA) for Janssen COVID-19 Vaccine was issued by the Food and Drug Administration (FDA) on 2/27/21.
An EUA allows access to critical medical products that may help during a public health emergency. An EUA is different from approval/licensure.
The following criteria must be met for an EUA to be issued:
- The product will be used for a serious or life-threatening disease or condition.
- Based on the totality of scientific evidence available, it is reasonable to believe the product may be effective.
- The known and potential benefits of the product outweigh the known and potential risks of the product.
|Emergency Use Authorization of Janssen COVID-19 Vaccine